Recent Headlines
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
MoBiTec, Germany to Offer Cryogenic Vials for Embryo Cryopreservation by Vitrification Manufactured by Sumitomo, Japan
In cryopreservation vitrification is a common method used to preserve egg cells and embryos. Of utmost importance is that the oocyte or embryo is stored in a vessel that allows appropriate temperature modulation. - December 03, 2014 - MoBiTec GmbH
MoBiTec, Germany, Offers a New Range of Monofluorinated Nucleosides Manufactured by Dextra, UK
Fluorine introduction can lead to a modification of the reactivity of functional groups, alter conformational stability and, in pharmaceuticals, enhance metabolic stability. Over 30% of leading blockbuster drugs contain at least one fluorine atom. - November 29, 2014 - MoBiTec GmbH
Advanced Cancer Therapeutics’ PFK-158 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting Oncology Projects to Watch
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been chosen by Informa and Kantar Health as one of the “2014 Top 10 Most Interesting Oncology Projects to Watch” for its compound, PFK-158. PFK-158 is a small... - November 27, 2014 - Advanced Cancer Therapeutics
8.5K in Los Angeles Raises $33,000 for PBTF
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised $33,000 in Los Angeles on Nov. 22. The 8.5K event at Griffith Park honored local children with brain tumors. These Stars were Adam, Bella, Brittney, Caitlyn, Cassie,... - November 27, 2014 - Pediatric Brain Tumor Foundation
Creative Bioarray Announces Product Promotiom for Magic™ Serum-Free Freezing Medium
Creative Bioarray announces its product promotion for Magic™ serum-free freezing medium towards the worldwide market. - November 26, 2014 - Creative Bioarray
Creative Biomart’s Most-Favored Services List is Available Now
Creative Biomart, a world leading biotech company that offers recombinant proteins, antibodies, antigens and a wide range of biotech services worldwide, today has released its most favored services list officially. It was said that this was done to make them have a better understanding of what... - November 22, 2014 - Creative Biomart
AveXis to Present at the 26th Annual Piper Jaffray Healthcare Conference
AveXis, a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy, today announced that Mr. John Carbona, Chief Executive Officer, and Dr. Brian Kaspar will present at the 26th Annual Piper Jaffray... - November 21, 2014 - AveXis Inc.
Houston Runs to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised nearly $15,000 in Houston on Nov. 15. The 8.5K event at Discovery Green honored local children with brain tumors. These Stars were Mandy, Taylor, Tobin and... - November 20, 2014 - Pediatric Brain Tumor Foundation
Patent Awarded to AdvantaPure(R)’s AdvantaPass(TM) Clean Room Wall Pass-Through System; Ensures Room Isolation During Fluid Transfer
A United States patent has been awarded to AdvantaPass, a clean room wall pass-through system designed to transfer fluids between clean rooms during pharmaceutical and biopharmaceutical production. The system is the first of its kind to provide complete isolation between manufacturing suites when transferring multiple fluid lines through a single wall portal. AdvantaPass uses Single-Use components, such as tubing and seals, along with durable stainless steel in-wall parts. - November 20, 2014 - AdvantaPure
Available from MoBiTec GmbH: Unique Ready-to-Use Vectors for Live Cell Imaging of Nuclear Proteins
During cell division the kinetochore is the protein structure on chromatids where the spindle fibers attach to pull sister chromatids apart. MoBiTec now offers unique gene fusion constructs of proteins to investigate kinetochore formation and cell division. - November 20, 2014 - MoBiTec GmbH
Creative Diagnostics Announces Product Promotion for Antigens Towards the Worldwide Market
Creative Diagnostics - Quality monoclonal and polyclonal antibody provider for the global market at very substantial savings begins at this thanksgiving month. - November 19, 2014 - Creative Diagnostics
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Creative Bioarray’s High Quality Dry Bath Incubators
Creative Bioarray is a well-recognized biotech company. The company is specializing in providing bio-laboratory products and services such as human tissue, animal tissue, tissue array, microorganisms, cells, probes, cell services, biosample services, histology services, and also laboratory equipments. - November 16, 2014 - Creative Bioarray
Jake Worthington to Perform at Starry Night Houston
Houston native Jake Worthington, a recent finalist on The Voice, will perform at Starry Night Houston on Saturday, Nov. 15 at Discovery Green. The Pediatric Brain Tumor Foundation’s Starry Night 8.5K is an evening walk/run that shines a light on kids battling one of the deadliest forms of... - November 15, 2014 - Pediatric Brain Tumor Foundation
Atlanta, San Francisco Top $100,000 for Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted 875 participants in Atlanta and San Francisco on Nov. 8. At start time, the events had raised $116,000. The crowds came to the 8.5K events at Centennial Olympic Park... - November 15, 2014 - Pediatric Brain Tumor Foundation
MoBiTec GmbH, Germany, Offers New Bacillus Megaterium Strain for Gene Expression and Protein Production - YYBm1
MoBiTec GmbH expands its product line of tools for gene expression in Bacillus megaterium with the new expression host YYBm1. Strain YYBm1 is unable to utilize the expression system's inductor molecule xylose as carbon source. - November 13, 2014 - MoBiTec GmbH
MoBiTec GmbH's Supplier Peninsula Laboratories, USA, with New Corporate Website
Peninsula Laboratories International, Inc, USA, a leading supplier of superior immunology products, proudly announces its own corporate website www.penlabs.com. Formerly, PenLabs was integral part of Bachem's internet presence. - November 11, 2014 - MoBiTec GmbH
Creative Bioarray’s WISP-PTC Dry Bath Incubator
Creative Bioarray launches another brand new dry bath incubator: WISP-PTC Dry Bath Incubator, with the support of its advanced technology platform. - November 08, 2014 - Creative Bioarray
Creative Bioarray’s 3-in-I Mini Dry Bath Incubator
Creative Bioarray launches its 3-in-1 multifunctional Mini Dry Bath Incubator - WISP-TR Dry Bath Incubator. - November 06, 2014 - Creative Bioarray
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative Biomart
Amoy Diagnostics, China, Expands List of CE-Marked Real-Time PCR Kits for Cancer Diagnostics
Amoy Diagnostics, who recently appointed MoBiTec GmbH as distributor for Germany, proudly announces the availability of further CE-marked detection kits, which are based on a proprietary real-time PCR technology called “ADx-ARMS,” for Cancer Diagnostics. - October 24, 2014 - MoBiTec GmbH
Boston, Philadelphia Join Starry Night to Cure the Kids
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted more than 500 participants in Boston and Philadelphia on Oct. 18. At start time, the events had raised $61,000. The crowds came to the 8.5K events at Joe Moakley... - October 23, 2014 - Pediatric Brain Tumor Foundation
MoBiTec, Germany, and Amoy Diagnostics, China, Sign Distribution Agreement for the German Market
MoBiTec GmbH, Germany, focused on selling products for life science and IVD research, has entered into a distribution agreement with Amoy Diagnostics, China. Together with AmoyDx, MoBiTec will continue to expand its portfolio of premier brands. - October 19, 2014 - MoBiTec GmbH
Creative Diagnostics Releases the Hot Products of October for Monoclonal Antibodies
Creative Diagnostics announced the release of its hot products of Oct. 2014 for monoclonal antibodies. - October 17, 2014 - Creative Diagnostics
OutsourcePharma Advisory Board CRO Reviews Database Surpasses Growth Milestone
Online community of outsourcing decision makers doubles its CRO reviews database - October 15, 2014 - Life Science Strategy Group, LLC
Creative Biomart Newly Introduced It’s Fc Fusion Protein Production Service
Creative Biomart, a word leading Biotech Company had newly released its novel service of Fc Fusion Protein Production Service in the aim of providing more choices for the scientists conducting biomedical and immunology research. The potential clinical application of cytokins to modulate immune... - October 10, 2014 - Creative Biomart
Starry Night Chicago Raises Funds to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on childhood brain tumors, made its debut in Chicago on Oct. 4 with the support of more than 500 participants. At start time, the event had raised $46,000. The crowd came to the 8.5K at Arlington... - October 09, 2014 - Pediatric Brain Tumor Foundation
AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy
AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.
MoBiTec GmbH: PDE Inhibitors Show Sonic Effects on Prostate Cancer
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined. - October 02, 2014 - MoBiTec GmbH
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint service offerings in the biotech and pharma sectors in fundraising, company evolution and drug development. The partnership pools the corporate expertise of Ventac Partners with the regulatory expertise of CNS and expands the geographical reach of both. - September 22, 2014 - Ventac Partners
Signed Robin Williams Skate Deck Part of Auction to Benefit PBTF
Actor and comedian Robin Williams was well-known for his philanthropy, especially for children’s causes. Just a few months before his death, he signed a skateboard to be included in an auction to help children with brain tumors. Williams worked with the skate deck’s artist, Cody Gallo,... - September 21, 2014 - Pediatric Brain Tumor Foundation
Newsletter XVII is Available from MoBiTec GmbH, Germany
MoBiTec's periodical Newsletter, issued several times a year, informs about new, exciting products in the categoríes vector systems and gene expression, genomics, proteomics, fluorescence applications, cell biology, labware, and more. - September 19, 2014 - MoBiTec GmbH
Creative Biomart Morning Talk for Mutagenesis Services
Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative Biomart
VIRUN® NutraBIOsciences™ Granted Patent 261124 in India, Redesigns Website, Omega-3 Summit at Supply Side West and CEO is Again Scheduled to Speak at Cal Poly Pomona
VIRUN has been granted patent number 261124 titled, Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agents. Also, VIRUN has re-designed their website to include brands, a product description page, video as well as a news and PR page. Included in the newly renovated website is an events page; with the growing interest in VIRUN, such as scheduled forums, lectures, expos and webinars, it was imperative this new website share these experiences. - September 11, 2014 - VIRUN
F2G Limited, the UK-Based Antifungal Drug Discovery and Development Company, Announces a Major Funding Award from the Technology Strategy Board’s Biomedical Catalyst
F2G Limited, the UK-based antifungal drug discovery and development company, today announced a major funding award from the Technology Strategy Board’s Biomedical Catalyst. - September 11, 2014 - F2G Ltd
Creative Biomart Newly Introduced Its Stable Cell Line Service
Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative Biomart
Xeno Diagnostics Adds Dr. Daniel Wierda as Director of Research and Development
Addition of Top Talent Strengthens Fast-Growing Indianapolis Biotech CRO - September 10, 2014 - Xeno Diagnostics, LLC
F2G Ltd, the UK Antifungal Drug Discovery & Development Company, Today Announces Commencement of a Phase 1 Single Ascending Dose Study of a Novel Antifungal Agent
F2G Limited, the antifungal research and development company today announced a major milestone in the development of its novel IV/oral systemic antifungal (F901318) with the commencement of a Phase I clinical study. This study initiates the IV Phase I clinical development of F901318 with the oral... - September 04, 2014 - F2G Ltd
MoBiTec to Attend the 4. Joint Conference of the VAAM and DGHM in Dresden, Germany, Oct. 5-8, 2014
This year the DGHM (Society of Hygiene and Microbiology) and the VAAM (Association for General and Applied Microbiology), the biggest German societies in the area of microbiology, hold their annual conference as a joint conference in Dresden. - September 04, 2014 - MoBiTec GmbH
Creative Biomart Newly Released a Bunch of Over-Expression Lysates
Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative Biomart
MoBiTec, Germany, Offers Clickable Isoprenoids Manufactured by Echelon Biosciences, USA, Representing Exclusive Valuable Tools for Isoprenoid and Cancer Research
Isoprenoids are organic compounds composed of two or more units of hydrocarbons, with each unit consisting of five carbon atoms arranged in a specific pattern. Isoprenoids play widely varying roles in physiological processes of plants and animals. - August 31, 2014 - MoBiTec GmbH
Mac’s SET the PACE Race Superhero for a Day 5K Run/Walk
Join the Mac’s SET the PACE Race at Washington Park in Denver, CO. This event honors patients, survivors and their family members. Increasing awareness of prostate cancer and the importance of early detection with a fun day of activities for the whole family. - August 29, 2014 - Prostate Conditions Education Council
MoBiTec, Germany, Announces Availability of Ebola Virus (EBOV) Real Time RT-PCR Kit
Ebola hemorrhagic fever (Ebola HF) is a severe, often fatal disease in humans and nonhuman primates, caused by infection with Ebolavirus. The recent Ebola outbreak in West Africa is one of the largest Ebola outbreaks in history. - August 28, 2014 - MoBiTec GmbH
NC COIN Promotes Karen Shank to Business Development Director
Pharma, Software, and Medical Technology Veteran Developing K-12 Programming, Expanding Membership Base of Nonprofit Idea Accelerator - August 27, 2014 - COIN
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative Biomart
Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference
Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014 - Braasch Biotech LLC
MoBiTec GmbH to Attend Horizons in Molecular Biology Meeting in Goettingen, Germany, Sep 15-18, 2014
Horizons in Molecular Biology is an international symposium in the field of molecular life sciences, organized by PhD students of the MSc/PhD Molecular Biology Program - International Max Planck Research School (IMPRS). - August 24, 2014 - MoBiTec GmbH
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative Biomart